Focused ultrasound therapy adoption rate exceeds 40% by 2028
Resolves: At least 40% of confirmed TTTS cases in the US, UK, and EU receive focused ultrasound therapy as the primary intervention by December 31, 2028.
user-generated· adoption
Focused ultrasound therapy adoption rate exceeds 40% by 2028
Market overview
At least 40% of eligible TTTS cases in high-income countries will receive focused ultrasound therapy as first-line treatment, driven by NICE approval and continued positive trial data. This would mark a rapid shift from traditional invasive methods.
adoption prediction market
- Implied probability (Yes)
- 60%
- Closes
- 2028-12-31
About this prediction
Resolution criteria
At least 40% of confirmed TTTS cases in the US, UK, and EU receive focused ultrasound therapy as the primary intervention by December 31, 2028.
Source: user-generated
More adoption markets
- Enterprise adoption of Even Realities G2 smart glasses exceeds 500 companies by Q1 2027 — 58% Yes
- AI moderation adoption slows by 20% among gaming platforms — 65% Yes
- Ghana food movement expands to 50% more regions — 70% Yes
- Anthropic's Claude Code remote usage will decline 20% by Q3 2026 — 68% Yes
- Paradigm-backed AI startup achieves $1B+ valuation by 2028 — 60% Yes
- DeepSeek's token volume share exceeds 45% by December 2026 — 65% Yes
- Colombia diverts 30% of Arabica exports to EU by 2027-06-30 — 60% Yes
- Disney+ free tier adoption exceeds 15M users by Q2 2027 — 60% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…